These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 7895165)

  • 61. Herpes simplex virus type 1 targets the MHC class II processing pathway for immune evasion.
    Neumann J; Eis-Hübinger AM; Koch N
    J Immunol; 2003 Sep; 171(6):3075-83. PubMed ID: 12960333
    [TBL] [Abstract][Full Text] [Related]  

  • 62. HLA-DM acts as a molecular chaperone and rescues empty HLA-DR molecules at lysosomal pH.
    Kropshofer H; Arndt SO; Moldenhauer G; Hämmerling GJ; Vogt AB
    Immunity; 1997 Mar; 6(3):293-302. PubMed ID: 9075930
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Delivery of nascent MHC class II-invariant chain complexes to lysosomal compartments and proteolysis of invariant chain by cysteine proteases precedes peptide binding in B-lymphoblastoid cells.
    Morton PA; Zacheis ML; Giacoletto KS; Manning JA; Schwartz BD
    J Immunol; 1995 Jan; 154(1):137-50. PubMed ID: 7995933
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Stable surface expression of invariant chain prevents peptide presentation by HLA-DR.
    Roche PA; Teletski CL; Karp DR; Pinet V; Bakke O; Long EO
    EMBO J; 1992 Aug; 11(8):2841-7. PubMed ID: 1639058
    [TBL] [Abstract][Full Text] [Related]  

  • 65. T cell recognition of major histocompatibility complex class II complexes with invariant chain processing intermediates.
    Morkowski S; Goldrath AW; Eastman S; Ramachandra L; Freed DC; Whiteley P; Rudensky AYu
    J Exp Med; 1995 Nov; 182(5):1403-13. PubMed ID: 7595211
    [TBL] [Abstract][Full Text] [Related]  

  • 66. HLA-DM recognizes the flexible conformation of major histocompatibility complex class II.
    Chou CL; Sadegh-Nasseri S
    J Exp Med; 2000 Dec; 192(12):1697-706. PubMed ID: 11120767
    [TBL] [Abstract][Full Text] [Related]  

  • 67. DR alpha beta dimers released from complexes with invariant chain fail to stimulate alloreactive T cell clones.
    Demotz S
    Eur J Immunol; 1993 Sep; 23(9):2100-8. PubMed ID: 8370392
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Invariant chain dissociation from class II MHC is a catalyst for foreign peptide binding.
    Reyes VE; Daibata M; Espejo R; Humphreys RE
    Ann N Y Acad Sci; 1994 Aug; 730():338-41. PubMed ID: 8080205
    [No Abstract]   [Full Text] [Related]  

  • 69. Impaired antigen presentation by murine I-Ad class II MHC molecules expressed in normal and HLA-DM-defective human B cell lines.
    Weenink S; Averdunk H; Boston T; Boswarva V; Guery JC; Adorini L; Mellins E; McCluskey J; Gautam AM
    Int Immunol; 1997 Jun; 9(6):889-96. PubMed ID: 9199972
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Surface-expressed invariant chain (CD74) is required for internalization of human leucocyte antigen-DR molecules to early endosomal compartments.
    Moldenhauer G; Henne C; Karhausen J; Möller P
    Immunology; 1999 Mar; 96(3):473-84. PubMed ID: 10233730
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effect of decreasing the affinity of the class II-associated invariant chain peptide on the MHC class II peptide repertoire in the presence or absence of H-2M.
    Honey K; Forbush K; Jensen PE; Rudensky AY
    J Immunol; 2004 Apr; 172(7):4142-50. PubMed ID: 15034026
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Dissection of the HLA-DR4 peptide repertoire in endocrine epithelial cells: strong influence of invariant chain and HLA-DM expression on the nature of ligands.
    Muntasell A; Carrascal M; Alvarez I; Serradell L; van Veelen P; Verreck FA; Koning F; Abian J; Jaraquemada D
    J Immunol; 2004 Jul; 173(2):1085-93. PubMed ID: 15240697
    [TBL] [Abstract][Full Text] [Related]  

  • 73. HLA-DO increases bacterial superantigen binding to human MHC molecules by inhibiting dissociation of class II-associated invariant chain peptides.
    Pezeshki AM; Azar GA; Mourad W; Routy JP; Boulassel MR; Denzin LK; Thibodeau J
    Hum Immunol; 2013 Oct; 74(10):1280-7. PubMed ID: 23756162
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Class II-associated invariant chain peptide expression on myeloid leukemic blasts predicts poor clinical outcome.
    Chamuleau ME; Souwer Y; Van Ham SM; Zevenbergen A; Westers TM; Berkhof J; Meijer CJ; van de Loosdrecht AA; Ossenkoppele GJ
    Cancer Res; 2004 Aug; 64(16):5546-50. PubMed ID: 15313888
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cutting edge: HLA-DM functions through a mechanism that does not require specific conserved hydrogen bonds in class II MHC-peptide complexes.
    Zhou Z; Callaway KA; Weber DA; Jensen PE
    J Immunol; 2009 Oct; 183(7):4187-91. PubMed ID: 19767569
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Alternative Ii-independent antigen-processing pathway in leukemic blasts involves TAP-dependent peptide loading of HLA class II complexes.
    van Luijn MM; Chamuleau ME; Ressing ME; Wiertz EJ; Ostrand-Rosenberg S; Souwer Y; Zevenbergen A; Ossenkoppele GJ; van de Loosdrecht AA; van Ham SM
    Cancer Immunol Immunother; 2010 Dec; 59(12):1825-38. PubMed ID: 20820776
    [TBL] [Abstract][Full Text] [Related]  

  • 77. DM-mediated release of a naturally occurring invariant chain degradation intermediate from MHC class II molecules.
    Stebbins CC; Peterson ME; Suh WM; Sant AJ
    J Immunol; 1996 Dec; 157(11):4892-8. PubMed ID: 8943393
    [TBL] [Abstract][Full Text] [Related]  

  • 78. HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides.
    Riberdy JM; Newcomb JR; Surman MJ; Barbosa JA; Cresswell P
    Nature; 1992 Dec; 360(6403):474-7. PubMed ID: 1448172
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A pH-sensitive histidine residue as control element for ligand release from HLA-DR molecules.
    Rötzschke O; Lau JM; Hofstätter M; Falk K; Strominger JL
    Proc Natl Acad Sci U S A; 2002 Dec; 99(26):16946-50. PubMed ID: 12471156
    [TBL] [Abstract][Full Text] [Related]  

  • 80. How HLA-DM affects the peptide repertoire bound to HLA-DR molecules.
    Vogt AB; Kropshofer H; Hämmerling GJ
    Hum Immunol; 1997 May; 54(2):170-9. PubMed ID: 9297535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.